Literature DB >> 19918835

Massively regulated genes: the example of TP53.

Monica Hollstein1, Pierre Hainaut.   

Abstract

Intensive study of the TP53 gene over the last three decades has revealed a highly complex network of factors that regulate its performance. The gene has several promoters, alternative splicing occurs and there are alternative translation initiation sites. Up to 10 p53 isoforms have been identified. At the post-translational level, p53 activity depends on its quantity in the cell and on qualitative changes in its structure, intracellular localization, DNA-binding activity and interactions with other proteins. Both accumulation and activation are regulated by an intricate pattern of post-translational modifications, including phosphorylation, acetylation, ubiquitination, sumoylation, neddylation, methylation and glycosylation. The Mdm2 protein, a negative regulator of p53, is the most important determinant of p53 abundance and subcellular localization. Enzymes that post-translationally modify p53 by phosphorylation, methylation and acetylation fine-tune p53 binding to recognition sequences in DNA and p53 interactions with transcription cofactors at promoters of target genes, thereby exerting a discriminatory role in p53 function. This multitude of parameters determining expression, modification, accumulation and localization of p53 proteins may explain how a single gene can display an extensive repertoire of activities. Presumably this is needed, because the p53 protein can have such profound consequences for a cell.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19918835     DOI: 10.1002/path.2637

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  60 in total

1.  Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.

Authors:  Annemarie Koch; Jiri Hatina; Harald Rieder; Hans-Helge Seifert; Wolfgang Huckenbeck; Frank Jankowiak; Andrea R Florl; Robert Stoehr; Wolfgang A Schulz
Journal:  Cell Oncol (Dordr)       Date:  2012-06-06       Impact factor: 6.730

2.  Mechanisms of p53 activation and physiological relevance in the developing kidney.

Authors:  Karam Aboudehen; Sylvia Hilliard; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2012-01-11

3.  Building p53.

Authors:  Tamara Terzian; Guillermina Lozano
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

4.  Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis.

Authors:  Sihua Wang; Yuan Zhang; Yan Wang; Ping Ye; Jun Li; Huabin Li; Qingqing Ding; Jiahong Xia
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

Review 5.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

6.  ATM mediates interdependent activation of p53 and ERK through formation of a ternary complex with p-p53 and p-ERK in response to DNA damage.

Authors:  Jee-In Heo; Soo-Jin Oh; Yoon-Jung Kho; Jeong-Hyeon Kim; Hong-Joon Kang; Seong-Hoon Park; Hyun-Seok Kim; Jong-Yeon Shin; Min-Ju Kim; Minju Kim; Sung Chan Kim; Jae-Bong Park; Jaebong Kim; Jae-Yong Lee
Journal:  Mol Biol Rep       Date:  2012-05-11       Impact factor: 2.316

7.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

8.  Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs.

Authors:  Erica Ungewitter; Heidi Scrable
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

9.  Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development.

Authors:  Sharmistha Pal; Ravi Gupta; Hyunsoo Kim; Priyankara Wickramasinghe; Valérie Baubet; Louise C Showe; Nadia Dahmane; Ramana V Davuluri
Journal:  Genome Res       Date:  2011-06-28       Impact factor: 9.043

10.  Partial p53-dependence of anisomycin-induced apoptosis in PC12 cells.

Authors:  R Schipp; J Varga; J Bátor; M Vecsernyés; Z Árvai; M Pap; József Szeberényi
Journal:  Mol Cell Biochem       Date:  2017-04-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.